Did You Lose Money on Altimmune, Inc. (ALT)? Levi & Korsinsky Urges Investors to Act Before October 6, 2025

NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/altimmune-inc-lawsuit-submission-form-2?prid=161979&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

ParaZero Receives Order from a Defense Entity for its Counter Drone Technology

(NASDAQ:PRZO), Kfar Saba, Israel, Aug. 18, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced that it has received a purchase order for its advanced Counter-Unmanned Aerial Systems (C-UAS) solution from

ParaZero Receives Order from a Defense Entity for its Counter Drone Technology

ParaZero Receives Order from a Defense Entity for its Counter Drone Technology GlobeNewswire August 18, 2025 Kfar Saba, Israel, Aug. 18, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced that

Lost Money on Evolent Health, Inc.(EVH)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Evolent Health, Inc. ("Evolent Health, Inc.") (NYSE:EVH) concerning possible violations of federal securities laws. On August 8, 2025, Evolent issued a press release announcing second quarter revenue results that were below analysts’

Levi & Korsinsky Urges Capricor (CAPR) Shareholders to Act Before Lead Plaintiff Deadline September 15, 2025

NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=161980&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Aehr Test Systems to Participate in the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 20

FREMONT, CA / ACCESS Newswire / August 18, 2025 / Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will participate in the 6th Annual Needham Virtual Semiconductor and SemiCap 1×1 Conference on Wednesday, August 20, 2025. Aehr Test President and CEO Gayn Erickson and CFO Chris

Mattr Appoints New Director

(TSX:MATR),(OTC US:MTTRF),(Other OTC:MTTRF), TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced the appointment of Jane Skoblo as a director of the Company effective August 13, 2025. Ms. Skoblo will serve on both the Audit and Compensation & Organizational Development Committees of Mattr. Ms. Skoblo's addition to the

Shareholders That Lost Money on Sabre Corporation(SABR) Should Contact Levi & Korsinsky about Securities Fraud Investigation – SABR

NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sabre Corporation ("Sabre Corporation") (NASDAQ:SABR) concerning possible violations of federal securities laws. On August 7, 2025, Sabre announced disappointing second quarter results, missing revenue and earnings projections, and cutting its guidance for

The Next Wave of Cancer Innovation: How Breakthrough Therapies Are Redefining Treatment Paradigms

– Bristol Myers Squibb, Merck & Company, and GE Healthcare Technologies continue advancing the cancer care ecosystem through cutting-edge therapeutics and diagnostic innovations – Personalized and targeted cancer therapies are showing unprecedented promise, with novel approaches potentially revolutionizing how we treat and detect cancer – Propanc Biopharma emerges as a compelling early stage play with

DeFi Technologies Announces Inaugural Insights Symposium to Be Held in Frankfurt on September 25, 2025

DeFi Technologies Inc. (the “Company” or “DeFi Technologies”) (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance, today announced the launch of the DeFi Technologies Insights Symposium, with the inaugural session to take place in Frankfurt, Germany, on September 25, 2025. https://mma.prnewswire.com/media/2752315/DeFi_Technologies_Inc__DeFi_Technologies_Announces_Inaugural_Ins.jpg The

Scroll to Top